DNAprint Genomics (DNAG)

[ann441j]

"Said Dalton: "Rather than just blind treatment and everybody gets the same thing, each individual will have tailor-made therapies on their unique profile. I'm not talking decades. I'm talking a few years."

State and local governments contributed more than $35 million to get the collaboration started. Merck declined to specify the amount the company is investing in the partnership.

Moffitt spokeswoman Michelle Foley said the venture is part of a $20 million research program. The institute will contribute $1 million annually to the venture for five years. Moffitt, a nonprofit based in the University of South Florida, is Florida's only comprehensive cancer research center."

Ann